AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|
24.1 C
New York
Friday, September 18, 2026

Tag: 6

HIGH-GRADE SPODUMENE AND TANTALUM CONCENTRATES CONFIRMED AT CASE LAKE

Major Highlights Outstanding results from Dense Media Separation (DMS) and flotation test work confirm the high quality and added value of lithium at the...

Make a Splash with Summer Savings at Natural Grocers®, July 10-12, 2025

Customers can enjoy sizzling deals of up to 36% off and a chance to win a Lake Tahoe getaway, plus a fun in-store scavenger...

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients...

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

La Caisse and Fondaction invest $250 million by way of a subordinated loan to Boralex

MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (TSX: BLX) (“Boralex” or the “Company”) announces the closing of an additional corporate financing of $250 million by way of an unsecured subordinated loan with a term of 8 years. The investment is made by La Caisse (formerly CDPQ), which is providing an amount of $200 million, to which is added a $50 million investment by a new partner, Fondaction.

Flagship Communities Real Estate Investment Trust to Host Conference Call for Second Quarter 2025 Results

Not for distribution to U.S. newswire services or dissemination in the United States.

Recurrent Energy Energizes 1,200 MWh Storage Facility in Arizona Ahead of Peak Summer Demand

First of three projects with APS now in operation, delivering flexible capacity to the grid KITCHENER, ON, July 7, 2025 /PRNewswire/ -- Recurrent Energy, a...

La Caisse et Fondaction investissent 250 M$ sous forme de dette subordonnée dans Boralex

MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce la clôture d’un financement corporatif additionnel de 250 M$ sous forme de dette subordonnée non garantie d’une échéance de huit ans. L’investissement est réalisé conjointement par La Caisse (anciennement CDPQ), qui investit un montant de 200 M$, et par un nouveau partenaire, Fondaction, pour un montant de 50 M$.

Dow will shut down three upstream European assets in response to structural challenges in the region

Right-sizing upstream regional capacity, reducing merchant sale exposure, and removing higher-cost, energy-intensive assetsBuilding on April 2025 announcement through actions across the Company's three operating...

Kvika banki hf.: Share buyback programme paused

Reference is made to the announcement by Kvika banki hf. dated 6 July 2025, in which the Board of Kvika approved the initiation of merger discussions with Arion bank hf. 

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB). 

Nova Klúbburinn hf.: Framkvæmd endurkaupaáætlunar í viku 27

Í 27. viku 2025 keypti Nova Klúbburinn hf. 2.400.000 eigin hluti að kaupverði 11.604.000 kr. í samræmi við eftirfarandi:

International Petroleum Corporation Announces Results of Normal Course Issuer Bid

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB).
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 76,000 IPC common shares (ISIN: CA46016U1084) during the period of July 1 to 4, 2025 under IPC’s normal course issuer bid / share repurchase program (NCIB).

Festi hf.: Buyback program week 27

In week 27 2025, Festi purchased in total 165,000 own shares for total amount of 47,025,000 ISK as follows:

SOMA GOLD ANNOUNCES AGREEMENT TO ACQUIRE THE ESCONDIDA MINE IN ANTIOQUIA, COLOMBIA

Highlights: Fully-permitted gold mine with a rapid potential for scaleLocated within trucking distance of Soma's El Limón millHigh-grade vein system with an average diluted gold...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags6